Results 151 to 160 of about 22,731 (179)

Beyond the Ocular Surface: Nasal Sensory Input as a Driver of Reflex Lacrimation in Dogs

Veterinary Ophthalmology, Volume 29, Issue 2, March 2026.
ABSTRACT Objective To evaluate the effect of nasal mucosal anesthesia on aqueous tear secretion in dogs and to compare responses between brachycephalic and non‐brachycephalic breeds. Animal Studied Twenty healthy dogs (10 Australian Shepherds, 10 Boston Terriers). Procedures All dogs received 0.5 mL of 10% lidocaine or saline into one randomly selected
Shelley W. Cochran, Nick J. Millichamp, Lionel Sebbag   +2 more
wiley   +1 more source

Opioid Overdose Reversal With Nalmefene Nasal Spray: A Case Report. [PDF]

Cureus
Sucher M, Emmans L.
europepmc   +1 more source

<i>Glycyrrhiza glabra</i>-Based Nasal Spray as a Novel Treatment for Chronic Rhinosinusitis with Nasal Polyps: Efficacy in Symptom Reduction and Epithelial-Mesenchymal Transition Modulation. [PDF]

Int J Med Sci
Chang GH, Chang PJ, Cheng YC, Wu CY, Yang YH, Lin YS, Hsu CM, Tsai MS, Tsai YT, Yang PR.   +9 more
europepmc   +1 more source

FDA approves neffy nasal spray for treatment of anaphylaxis in adult and pediatric patients. [PDF]

Ann Med Surg (Lond)
Rahmat ZS, Chandwani R, Maqbool H, Malikzai A.   +3 more
europepmc   +1 more source

Nasal saline irrigation with azelastine-fluticasone nasal spray in moderate-to-severe persistent allergic rhinitis: a randomized controlled trial. [PDF]

Front Allergy
Li S, Xu R, Yu S, Wang M, Fan J, Chen M, Gong X, Gu Q, Chen F, Jin L, Geng C, Yan M, Qiu C, Lu M, Cheng L.   +14 more
europepmc   +1 more source

Erratum: Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 [Corrigendum]. [PDF]

Int J Nanomedicine
europepmc   +1 more source

Etripamil Nasal Spray for Recurrent Paroxysmal Supraventricular Tachycardia Conversion: Results From the NODE-303 Open-Label Study. [PDF]

J Cardiovasc Electrophysiol
Ip JE, Coutu B, Ip JH, Noseworthy PA, Parody ML, Rafii F, Sears SF, Singh N, Stambler BS, Tahirkheli NK, Agudelo-Uribe J, Hu D, Shardonofsky S, Sheikh MB, Holz A, Bharucha DB, Camm AJ.   +16 more
europepmc   +1 more source

Patient-Reported Outcomes During the Acute Treatment of Migraine with Zavegepant Nasal Spray: Results from a 52-Week, Open-Label Study. [PDF]

Pain Ther
Lipton RB, Mosher L, Fountaine RJ.
europepmc   +1 more source

Pharmacokinetics and 180-day safety of diazepam nasal spray in pediatric patients with epilepsy aged 2-5 years. [PDF]

Epilepsia
Segal EB, Wheless JW, Zafar M, Shih EK, Ngo LY, Carrazana E, Rabinowicz AL, DIAZ.001.008 Study Group.   +7 more
europepmc   +1 more source